Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
Operating Expenses | 1,307 | 934 | 1,290 | 1,429 | 1,318 |
Operating Income | -1,307 | -934 | -1,290 | -1,429 | -1,318 |
Interest Expense | 1 | 1 | 2 | 392 | 105 |
Other Income | 0 | 0 | 1 | 0 | 0 |
Pre-tax Income | -1,308 | -935 | -1,291 | -1,821 | -1,423 |
Net Income Continuous | -1,308 | -935 | -1,291 | -1,821 | -1,423 |
Net Income | $-1,308 | $-935 | $-1,291 | $-1,821 | $-1,423 |
EPS Basic Total Ops | -19.88 | -13.25 | -23.19 | -39.75 | -29.81 |
EPS Basic Continuous Ops | -20.67 | -14.44 | -23.21 | -38.11 | -30.35 |
EPS Diluted Total Ops | -19.88 | -13.25 | -23.19 | -39.75 | -29.81 |
EPS Diluted Continuous Ops | -20.67 | -14.44 | -23.21 | -38.11 | -30.35 |
EBITDA(a) | $-1,277 | $-901 | $-1,252 | $-1,028 | $-1,198 |